SMG1 and triple-A syndrome: Through machine learning and rigorous validation procedures, we have identified PLCH2, PRKCQ, and SMG1 as diagnostic biomarkers for telomere-associated AAA, exhibiting an upward expression trend in AAA compared to the control group.